SME Times is powered by   
Search News
Just in:   • GDP up but job security falls: Only 16 pc earn regular wage  • 'Indian chemical industry to surge to $226 bn in three years'  • British judge to decide on Mallya arrest warrant  • Agency banks, RBI offices to remain open till April 1  • 'Hunar Hubs' to be set up for artisans from minorities: Naqvi 
Last updated: 23 Feb, 2017  

Lupin receives FDA approval for tablets, oral solution
SME Times News Bureau | 01 Mar, 2017
Pharma major Lupin Limited on Tuesday said that it has received final approval for its Oxycodone and Acetaminophen tablets and sodium, potassium and magnesium sulphate oral solution from the US Food and Drug Administration (FDA).
  Read more....
Pharma pricing regulator cuts stent prices by up to 85 pc
SME Times News Bureau | 15 Feb, 2017
In a major measure of relief to cardiac patients in India, the government on Tuesday fixed the ceiling price of coronary stents which are used to open up blocked arteries.
  Read more....
Trump's decision could hit Indian pharma exporters
SME Times News Bureau | 01 Feb, 2017
Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald Trump told drug makers on Monday to bring back manufacturing to the United States.
  Read more....
Biocon gets Rs 460 cr insulin order from Malaysia
SME Times News Bureau | 27 Jan, 2017
Biotech major Biocon on Thursday said its Malaysian subsidiary has won a Rs 460 crore order to supply recombinant human insulin to the Malaysian health ministry.
  Read more....
Zydus arm acquires six drugs from MSD
SME Times News Bureau | 29 Dec, 2016
Pharma major Zydus Cadila on Wednesday announced that its healthcare arm had acquired six brands from US drug maker MSD and its subsidiaries for an undisclosed amount.
  Read more....
Cabinet approves sale of surplus land of 4 pharma PSUs
SME Times News Bureau | 29 Dec, 2016
The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday approved need-based sale of surplus land of Hindustan Antibiotics Ltd (HAL), Indian Drugs & Pharmaceuticals Ltd (IDPL), Rajasthan Drugs & Pharmaceuticals Ltd (RDPL) and Bengal Chemicals & Pharmaceuticals Ltd (BCPL) to meet their outstanding liabilities.
  Read more....
Cipla plans to raise Rs 4,000 crore
SME Times News Bureau | 20 Dec, 2016
Pharma major Cipla on Monday said that it plans to raise Rs 4,000 crore through the issue of various securities, subject to regulatory approvals.
  Read more....
'Central regulations for ayurvedic industry soon'
SME Times News Bureau | 05 Dec, 2016
The AYUSH Ministry is planning to draw up a central regulatory framework for ayurvedic industry, an official said on Sunday.
  Read more....
USD 60 mn deal: Sun Pharma to acquire Russian company
SME Times News Bureau | 23 Nov, 2016
Drug major Sun Pharmaceutical Industries Ltd on Wednesday said it has entered into an agreement to acquire Russian pharma company JSC Biosintez for USD 24 million.
  Read more....
Biocon net up 52% in second quarter
SME Times News Bureau | 21 Oct, 2016
Biotech major Biocon Ltd on Thursday reported Rs 147 crore consolidated net profit for second quarter (July-September) of fiscal 2016-17, registering 57 percent annual growth from Rs 97 crore in same period year ago.
  Read more....
  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.55 56.65
As on 27 Mar, 2017
  Daily Poll
Do you think proposed US visa rules will hurt Indian IT sector?
 Can't say
  Commented Stories
» It's time for SMEs to go online(10)
» Starting an import export business: Basic guide for beginners(8)
» MSME schemes - Do you know all of them?(4)
» SBI Launches Home Loans for Govt. and Defence Employees(1)
» GST: 'No clarity yet on tax on services a worry'(1)
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter